Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Okada

Showing results (71-80 of 277) with videos related to

Pageof 28
Sort By:
Cureus|February 27, 2023
A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic ControlTadashi Arao, Yosuke Okada, Akira Kurozumi, et al.
Journal of UOEH|March 20, 2015
Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case reportSunao Yamamoto, Yosuke Okada, Tadashi Arao, et al.
Diabetology & Metabolic Syndrome|August 21, 2020
Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot studyAkemi Tokutsu, Yosuke Okada, Keiichi Torimoto, et al.
Endocrine Journal|July 21, 2012
A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndromeKeiichi Torimoto, Yosuke Okada, Tadashi Arao, et al.
Journal of UOEH|June 7, 2021
Work Environment-related Stress Factors are Correlated with Diabetes Development in Workers with Impaired Glucose Tolerance: A 5-year Follow-up Study Using the Brief Job Stress Questionnaire (BJSQ)Motoko Sugito, Yosuke Okada, Keiichi Torimoto, et al.
Journal of UOEH|September 15, 2017
A Case of Acromegaly in which a Pituitary Gland Tumor was Reduced Significantly by Administering Octreotide Long Acting Release (LAR) and Could Be Removed SurgicallyTadashi Arao, Yosuke Okada, Fumi Uemura, et al.
Journal of Diabetes Investigation|July 9, 2016
Factors influencing inter-day glycemic variability in diabetic outpatients receiving insulin therapyHiroko Mori, Yosuke Okada, Akira Kurozumi, et al.
Diabetes Technology & Therapeutics|August 3, 2018
Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose MonitoringKeiichi Torimoto, Yosuke Okada, Maiko Hajime, et al.
Clinical Calcium|April 4, 2006
[Primary hyperparathyroidism complicated with flail chest due to severe osteoporosis]Kazuko Kanda, Yosuke Okada, Tadashi Arao, et al.
Biochemical and Biophysical Research Communications|May 15, 2003
Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cellsTakahiro Tabata, Shinichiro Mine, Chie Kawahara, et al.
Pageof 28

Showing results (71-80 of 277) with videos related to

Sort By:
Pageof 28
Cureus|February 27, 2023
A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic ControlTadashi Arao, Yosuke Okada, Akira Kurozumi, et al.
Journal of UOEH|March 20, 2015
Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case reportSunao Yamamoto, Yosuke Okada, Tadashi Arao, et al.
Diabetology & Metabolic Syndrome|August 21, 2020
Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot studyAkemi Tokutsu, Yosuke Okada, Keiichi Torimoto, et al.
Endocrine Journal|July 21, 2012
A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndromeKeiichi Torimoto, Yosuke Okada, Tadashi Arao, et al.
Journal of UOEH|June 7, 2021
Work Environment-related Stress Factors are Correlated with Diabetes Development in Workers with Impaired Glucose Tolerance: A 5-year Follow-up Study Using the Brief Job Stress Questionnaire (BJSQ)Motoko Sugito, Yosuke Okada, Keiichi Torimoto, et al.
Journal of UOEH|September 15, 2017
A Case of Acromegaly in which a Pituitary Gland Tumor was Reduced Significantly by Administering Octreotide Long Acting Release (LAR) and Could Be Removed SurgicallyTadashi Arao, Yosuke Okada, Fumi Uemura, et al.
Journal of Diabetes Investigation|July 9, 2016
Factors influencing inter-day glycemic variability in diabetic outpatients receiving insulin therapyHiroko Mori, Yosuke Okada, Akira Kurozumi, et al.
Diabetes Technology & Therapeutics|August 3, 2018
Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose MonitoringKeiichi Torimoto, Yosuke Okada, Maiko Hajime, et al.
Clinical Calcium|April 4, 2006
[Primary hyperparathyroidism complicated with flail chest due to severe osteoporosis]Kazuko Kanda, Yosuke Okada, Tadashi Arao, et al.
Biochemical and Biophysical Research Communications|May 15, 2003
Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cellsTakahiro Tabata, Shinichiro Mine, Chie Kawahara, et al.
Pageof 28